tradingkey.logo
tradingkey.logo
Search

Clearpoint Neuro Inc

CLPT
Add to Watchlist
14.610USD
-0.360-2.40%
Close 09-24 16:00(ET)
438.15MMarket Cap
LossP/E TTM

Clearpoint Neuro Inc (CLPT) Revenue Performance

Updated: Jun 30, 2026

Last year, Clearpoint Neuro Inc generated 14.83M USD for its biggest-performing segment, Products: Functional neurosurgery. The United States made the largest contribution, accounting for 36.97M USD last year. For the latest quarter, Clearpoint Neuro Inc reported the revenue of 5.55M USD for the period ending 2026-06-30, which came from the top-performing segment, Products: Functional neurosurgery. United States contributed the highest revenue, at 10.88M USD.

By Business

Annual
Annual
Quarterly
Products: Functional neurosurgery
Services: Biologics and drug delivery
Products: Biologics and drug delivery
Product Systems and software products
Services: Capital equipment and other
Services -Functional neurosurgery navigation and therapy
Products: Capital equipment
Services Therapy
Products:Therapy
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
Products: Functional neurosurgery
14.83M(40.12%)
10.29M(32.77%)
7.59M(31.68%)
7.59M(36.92%)
7.70M(47.22%)
6.27M(48.88%)
6.88M(61.37%)
Services: Biologics and drug delivery
11.70M(31.65%)
11.70M(37.29%)
11.45M(47.79%)
5.43M(26.42%)
3.44M(21.12%)
3.58M(27.87%)
889.70K(7.93%)
Products: Biologics and drug delivery
7.34M(19.85%)
5.61M(17.86%)
2.15M(8.99%)
3.69M(17.96%)
3.35M(20.57%)
1.47M(11.44%)
1.46M(13.01%)
Product Systems and software products
1.69M(4.57%)
2.73M(8.71%)
860.00K(3.59%)
1.51M(7.36%)
864.00K(5.30%)
440.00K(3.43%)
--(--)
Services: Capital equipment and other
1.41M(3.81%)
1.06M(3.38%)
973.00K(4.06%)
795.00K(3.87%)
569.00K(3.49%)
1.05M(8.18%)
625.87K(5.58%)
Services -Functional neurosurgery navigation and therapy
--(--)
--(--)
931.00K(3.89%)
1.54M(7.48%)
375.00K(2.30%)
25.00K(0.19%)
--(--)
Products: Capital equipment
--(--)
--(--)
--(--)
--(--)
--(--)
--(--)
1.04M(9.24%)
Services Therapy
--(--)
--(--)
--(--)
--(--)
--(--)
--(--)
225.00K(2.01%)
Products:Therapy
--(--)
--(--)
--(--)
--(--)
--(--)
--(--)
96.92K(0.86%)

By Region

Annual
Annual
Quarterly
United States
FY2025
FY2024
FY2023
United States
36.97M(100.00%)
31.39M(100.00%)
23.95M(100.00%)
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.